ADAP 241220 0.50C (ADAP241220C500) Stock Options, News & Quotes

US OptionsDetailed Quotes

ADAP241220C500

Watchlist

0.20
+0.05+33.33%

15min DelayClose Nov 22 16:00 ET

0.20High0.15Low

Intraday

5D
Daily

News

Adaptimmune Therapeutics Analyst Ratings
BenzingaNov 19 12:41 ET · Ratings
European Equities Traded in the US as American Depositary Decline Slightly in Tuesday Trading
MT NewswiresNov 19 11:18 ET
H.C. Wainwright Maintains Adaptimmune Therapeutics(ADAP.US) With Buy Rating, Maintains Target Price $3.5
Moomoo NewsNov 19 10:32 ET · Ratings
Promising Future for Adaptimmune Therapeutics: Buy Rating Supported by Breakthrough Therapies and Strong Financial Position
TipRanksNov 19 09:35 ET · Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Adaptimmune Therapeutics (ADAP), Fulcrum Therapeutics (FULC) and Immunic (IMUX)
TipRanksNov 19 02:20 ET · Ratings
Adaptimmune Therapeutics Third Quarter 2024 Earnings: Beats Expectations
Yahoo FinanceNov 16 07:19 ET

Comments

Trytosaveabit

Nov 13 16:14

Not to shabby!

$Adaptimmune Therapeutics (ADAP.US)$ Plus DATA to be presented for IGNYTE-ESO Trial of LETE-CEL in patients with SYNOVIAL SARCOMA! on 11/16/24 Saturday at CTOS annual meeting! ((((. Financial Results for the three and nine months ended September 30, 2024
● Cash / liquidity position: As of September 30, 2024, Adaptimmune had cash and cash equivalents of $116.7 million and Total Liquidity2 of $186.1 million, compared to $144.0 million and $146.9 million respectively, as of December 31...

Stock_Drift

Nov 13 08:09

$Adaptimmune Therapeutics (ADAP.US)$

101674396

Oct 31 03:35

$Adaptimmune Therapeutics (ADAP.US)$ .. green when is the pre-market , will drop once open market!!!

Trytosaveabit

Sep 23 17:44

Newly filed 8K

$Adaptimmune Therapeutics (ADAP.US)$ Item 1.01Entry into a Material Definitive Agreement.
On September 23, 2024, Adaptimmune Therapeutics plc (the “Company”) entered into a Mutual Release and Resolution Agreement (the “Agreement”) with Genentech Inc and F. Hoffmann-La Roche Ltd, (together “Genentech”). The parties entered into the Agreement following notice of termination of their Collaboration and License Agreement dated September 3, 2021 (the “Collaboration Agreement”) on April 8,...

Tonyco

Sep 8 17:22

$Adaptimmune Therapeutics (ADAP.US)$
so the spike in cash is from financing, fyi